MedTrace Logo

Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy

NCT01396551 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2019-01-02

Study results available
· View outcomes & findings →

Summary

Clinical study investigating the feasibility and safety of using an anchored Calypso transponder in the airways of the lung for real-time monitoring of tumor location during radiotherapy

Conditions

Interventions

DEVICE

Implantation of anchored Beacon transponder in the lung

Anchored Beacon transponder has an anchoring feature to secure it in the small airways of the lung.

Sponsors & Collaborators

  • Varian, a Siemens Healthineers Company

    lead INDUSTRY

Principal Investigators

  • Lisa Levine, PhD · Varian Medical Systems

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2016-12-31
Completion
2017-01-31
FDA Device
Yes

Countries

  • United States
  • Germany
  • South Africa
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01396551 on ClinicalTrials.gov